Hoth Therapeutics (HOTH) News Today $0.84 +0.02 (+2.04%) (As of 12:00 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Hoth Up on Bitcoin BuyNovember 20 at 2:42 PM | baystreet.caHoth Therapeutics Board of Directors Approves Bitcoin as Treasury Reserve AssetNovember 20 at 7:38 AM | prnewswire.comHoth Therapeutics shares hold buy as study shows cancer treatment promiseNovember 7, 2024 | investing.comHoth Therapeutics Up 34% on Favorable Early Data for Preclinical Study of Cancer DrugOctober 30, 2024 | marketwatch.comHoth Therapeutics: Treatment ‘successfully’ stabilized tumor growth in studyOctober 30, 2024 | markets.businessinsider.comHoth Therapeutics Announces Update on Cancer Therapeutic HT-KIT Results Suggesting the Treatment Effectively Inhibited Tumor Growth in Preclinical Treatment StudyOctober 29, 2024 | prnewswire.comHoth Therapeutics, Inc.October 17, 2024 | cnn.comHoth Shares Rise After Alzheimer's Treatment Gets PatentOctober 15, 2024 | marketwatch.comHoth Therapeutics Awarded Key US Patent for Groundbreaking Alzheimer's Treatment and Prepares for Clinical Trials of HT-ALZ with Formulation Now UnderwayOctober 15, 2024 | prnewswire.comHoth Therapeutics Reports Encouraging Pre-clinical Data For Its Alzheimer's Drug; Stock UpSeptember 17, 2024 | markets.businessinsider.comHoth Therapeutics Shares Rally on Positive Alzheimer's Pre-clinical Study DataSeptember 17, 2024 | marketwatch.comHoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZSeptember 17, 2024 | prnewswire.comHoth Therapeutics (NASDAQ:HOTH) Stock Quotes, Forecast and News SummarySeptember 6, 2024 | benzinga.comEvolve Canadian Utilities Enhanced Yield Index Fund (UTES.TO)September 5, 2024 | finance.yahoo.comHoth Stock Soars On Announcement Of Positive Data For HT-001 In EGFRI-Associated Skin ToxicitiesSeptember 5, 2024 | markets.businessinsider.comHoth Therapeutics Reports Favorable Results for First-of-Its-Kind HT-001 Treatment of a PatientSeptember 5, 2024 | marketwatch.comHoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a TrialSeptember 5, 2024 | prnewswire.comHoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001September 5, 2024 | prnewswire.comPhanes acquires second FDA orphan designation for bispecific antibodyAugust 20, 2024 | msn.comHoth Therapeutics, Inc. (NASDAQ:HOTH) CEO Acquires 25,000 SharesAugust 20, 2024 | insidertrades.comHoth Therapeutics, Inc. (HOTH) latest stock news & headlines – Yahoo FinanceAugust 18, 2024 | nz.finance.yahoo.comHoth and Aronnax partner for HT-KIT cancer therapy developmentAugust 16, 2024 | finance.yahoo.comHoth, Aronnax Enter Master Services Agreement For HT-KIT Therapeutic - Quick FactsAugust 15, 2024 | markets.businessinsider.comHoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer TherapeuticAugust 15, 2024 | prnewswire.comBuy Rating Affirmed for Hoth Therapeutics on Strategic Partnerships and Promising Alzheimer’s Treatment AdvancesJuly 26, 2024 | markets.businessinsider.comMicro Cap Already Off To The Races At The BellJuly 24, 2024 | theglobeandmail.comWhy Is Hoth Therapeutics (HOTH) Stock Moving Today?July 24, 2024 | investorplace.comHoth Signs Deal With LTS Therapy To Develop & Manufacture HT-ALZ Oral Film Prot; Stock UpJuly 24, 2024 | markets.businessinsider.comHoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's TreatmentJuly 24, 2024 | prnewswire.comHoth Therapeutics’ Expansion and AI Integration Bolster Buy RatingJuly 22, 2024 | markets.businessinsider.comHoth Therapeutics Expands Clinical Trial for Cancer PatientsJuly 16, 2024 | prnewswire.comHoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug DiscoveryJune 10, 2024 | prnewswire.comHoth Therapeutics, Inc. (HOTH) Stock Price, News, Quote & History - Yahoo FinanceMay 23, 2024 | finance.yahoo.comHOTH Stock Earnings: Hoth Therapeutics Misses EPS for Q1 2024May 15, 2024 | investorplace.comHoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024May 1, 2024 | prnewswire.comHoth Therapeutics files to sell 5.03M shares of common stock for holdersApril 12, 2024 | msn.comThe Brickyard, Carlisle to welcome popular rock band Elias T HothApril 2, 2024 | msn.comHoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross ProceedsMarch 27, 2024 | prnewswire.comHoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity TreatmentMarch 27, 2024 | prnewswire.comHoth Therapeutics Shares Soar on Positive Data from Alzheimer's StudyMarch 19, 2024 | marketwatch.comWhy Is Alzheimer's-Focused Hoth Therapeutics Stock Trading Higher On Tuesday?March 19, 2024 | msn.comHoth Therapeutics, Inc.: Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZMarch 19, 2024 | finanznachrichten.deGraphite Bio, SCWorx, Acurx Pharmaceuticals among healthcare moversMarch 19, 2024 | msn.comHoth Therapeutics: Pre-clinical Research Shows HT-ALZ's Profound Impact On Alzheimer's PathologyMarch 19, 2024 | markets.businessinsider.comHoth stock rallies 24% on preclinical Alzheimer's dataMarch 19, 2024 | msn.comHoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZMarch 19, 2024 | prnewswire.comHoth Therapeutics Retains Venable LLP to Expand Its Patent PortfolioFebruary 29, 2024 | finance.yahoo.comHoth Therapeutics, Inc.: Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting TherapeuticFebruary 26, 2024 | finanznachrichten.deHoth Therapeutics Partners Altasciences For Study On HT-KIT Cancer TreatmentFebruary 26, 2024 | markets.businessinsider.comHoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting TherapeuticFebruary 26, 2024 | prnewswire.com Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. HOTH Media Mentions By Week HOTH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HOTH News Sentiment▼-0.820.47▲Average Medical News Sentiment HOTH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HOTH Articles This Week▼21▲HOTH Articles Average Week Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Chemomab Therapeutics News Calidi Biotherapeutics News Tempest Therapeutics News Cocrystal Pharma News Pulmatrix News Acurx Pharmaceuticals News Exicure News Lakeshore Biopharma News iBio News MIRA Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HOTH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hoth Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hoth Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
